» Articles » PMID: 16636049

Screening for the Preferred Substrate Sequence of Transglutaminase Using a Phage-displayed Peptide Library: Identification of Peptide Substrates for TGASE 2 and Factor XIIIA

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Apr 26
PMID 16636049
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian transglutaminase (TGase) catalyzes covalent cross-linking of peptide-bound lysine residues or incorporation of primary amines to limited glutamine residues in substrate proteins. Using an unbiased M13 phage display random peptide library, we developed a screening system to elucidate primary structures surrounding reactive glutamine residue(s) that are preferred by TGase. Screening was performed by selecting phage clones expressing peptides that incorporated biotin-labeled primary amine by the catalytic reactions of TGase 2 and activated Factor XIII (Factor XIIIa). We identified several amino acid sequences that were preferred as glutamine donor substrates, most of which have a marked tendency for individual TGases: TGase 2, QxPphiD(P), QxPphi, and QxxphiDP; Factor XIIIa, QxxphixWP (where x and phi represent a non-conserved and a hydrophobic amino acid, respectively). We further confirmed that the sequences were favored for transamidation using modified glutathione S-transferase (GST) for recombinant peptide-GST fusion proteins. Most of the fusion proteins exhibited a considerable increase in incorporation of primary amines over that of modified GST alone. Furthermore, we identified the amino acid sequences that demonstrated higher specificity and inhibitory activity in the cross-linking reactions by TGase 2 and Factor XIIIa.

Citing Articles

Transglutaminase 1: Emerging Functions beyond Skin.

Samani S, Tatsukawa H, Hitomi K, Kaartinen M Int J Mol Sci. 2024; 25(19).

PMID: 39408635 PMC: 11476513. DOI: 10.3390/ijms251910306.


In silico studies of the open form of human tissue transglutaminase.

Ivashchenko S, Shulga D, Ivashchenko V, Zinovev E, Vlasov A Sci Rep. 2024; 14(1):15981.

PMID: 38987418 PMC: 11236986. DOI: 10.1038/s41598-024-66348-8.


Preclinical evaluation of an F-labeled N-acryloyllysine piperazide for covalent targeting of transglutaminase 2.

Wodtke R, Laube M, Hauser S, Meister S, Ludwig F, Fischer S EJNMMI Radiopharm Chem. 2024; 9(1):1.

PMID: 38165538 PMC: 10761660. DOI: 10.1186/s41181-023-00231-1.


Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition-Evidence for the Role for TG1 in Osteoclast Formation.

Samani S, Kaartinen M Cells. 2023; 12(17).

PMID: 37681871 PMC: 10487146. DOI: 10.3390/cells12172139.


Development of peptide-based biosensors for detecting cross-linking and deamidation activities of transglutaminases.

Tatsukawa H, Aoyama R, Hitomi K Amino Acids. 2023; 55(6):807-819.

PMID: 37165293 DOI: 10.1007/s00726-023-03272-7.